Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23851911 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.
Condition: HIV Integrase, HIV Protease.
Interventions: Drug: Raltegravir;   Drug: Darunavir

Study has passed its completion date and status has not been verified in more than two years.